Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H43N.ClH |
| Molecular Weight | 334.023 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCCCCCCCCCCCCCCCN(C)C
InChI
InChIKey=PFKRTWCFCOUBHS-UHFFFAOYSA-N
InChI=1S/C20H43N.ClH/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(2)3;/h4-20H2,1-3H3;1H
Dymanthine (Thelmesan) is an Anthelmintic, it is prepared as the hydrochloride and has some activity against hookworm infection, ascariasis, trichuriasis and hymenolepiasis. The drug appears to be safe, well tolerated and to cause few side effects (nausea, vomiting, headache, diarrhea, giddiness).
Originator
Sources: https://www.trademarkia.com/ca/trademark-280094.htm
Curator's Comment: # Pfizer
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Treatment of ascariasis, trichuriasis, hymenolepiasis and giardiasis with single doses of Thelmesan]. | 1968-10 |
|
| [Treatment of hymenolepiasis with dymanthine HCl]. | 1968-05 |
|
| Dymanthine hydrochloride (thelmasan) in multiple intestinal helmintic infestations. | 1967-03 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2110847
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
300000055442
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
DTXSID2049680
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
1613-17-8
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
15364
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
216-559-0
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
C65502
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
JAD662Q3U7
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
C007569
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
5547
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | |||
|
m4792
Created by
admin on Mon Mar 31 18:18:13 GMT 2025 , Edited by admin on Mon Mar 31 18:18:13 GMT 2025
|
PRIMARY | Merck Index |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD